Intensive exercise and its effect on the heart: Is more always better?

Regular physical exercise is undoubtedly beneficial for humans. Since the 1950s, numerous prospective follow-up studies have assessed both all-cause and cardiovascular (CV) mortality in relation to levels of physical activity. The results have always been unambiguous. Both men and women who presented with higher levels of physical activity were found to have a reduced risk of death (by up to 50%). Noteworthy, those who maintain a physically active lifestyle but at the same time present with other risk factors for CV diseases (CVD; smoking, hyperlipidemia, hypertension, diabetes, obesity) appear to be at a lower risk of premature death than sedentary subjects without risk factors [1]. Physical activity reduces the incidence of hypertension, ischemic heart disease and CV events, type 2 diabetes, cancers (in particular colon and breast cancer) and osteoporosis [2]. Furthermore, when applied in the secondary prevention of CVD, regular physical exercise, regular physical exercise reduces all-cause mortality. Whether for health-related reasons or not, the number of people participating in sports activities is increasing and healthy lifestyle has indeed become fashionable in the last decade. In addition, extreme forms of endurance exercise such as marathon, triathlon and ironman triathlon have become increasingly popular among amateurs. Globally, the number of marathon runners increased by 13% in 2009–2014 and 0.5% of the United States population participated in at least one marathon [3, 4]. Amateur participation in these extreme sports is associated with the need for hours of training, often daily, and competitions are exhausting. Thus, a question arises whether in spite of undisputable health benefits connected with physical activity, such intensive forms of endurance sport still continue to be so, or if they can adversely affect the cardiovascular system. Is more always better?

[1]  R. Khokha,et al.  Tumor Necrosis Factor- Mediates Cardiac Remodeling and Ventricular Dysfunction After Pressure Overload State , 2007 .

[2]  D. Pascual-Figal,et al.  Clinical relevance of sST2 in cardiac diseases , 2016, Clinical chemistry and laboratory medicine.

[3]  K. Brown,et al.  Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension , 2016, Heart and Vessels.

[4]  J. Ganame,et al.  Reduced right ventricular ejection fraction in endurance athletes presenting with ventricular arrhythmias: a quantitative angiographic assessment. , 2007, European heart journal.

[5]  K. Connelly,et al.  Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise , 2007, Heart.

[6]  R. Kronmal,et al.  Pentraxin-3 and the Right Ventricle: The Multi-Ethnic Study of Atherosclerosis–Right Ventricle Study , 2014, Pulmonary circulation.

[7]  A. Gressner,et al.  Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. , 1992, Clinical immunology and immunopathology.

[8]  I. Macdonald,et al.  Brief exercise induces an immediate and a delayed leucocytosis. , 1991, British journal of sports medicine.

[9]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[10]  Hein Heidbüchel,et al.  Disproportionate exercise load and remodeling of the athlete's right ventricle. , 2011, Medicine and science in sports and exercise.

[11]  G. Morris,et al.  Tumour necrosis factor alpha in severe congestive cardiac failure. , 1993, British heart journal.

[12]  A. Jaffe,et al.  Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure. , 2016, Journal of cardiac failure.

[13]  Maurizio Schiavon,et al.  Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[14]  Douglas L. Jones,et al.  Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFα , 2015, Nature Communications.

[15]  T. Wakatsuki,et al.  Pentraxin 3 is a local inflammatory marker in atrial fibrillation , 2011, Heart and Vessels.

[16]  J. Nielsen,et al.  Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[17]  G. Raczak,et al.  Neopterin and interleukin-6 as predictors of recurrent atrial fibrillation , 2015, Anatolian journal of cardiology.

[18]  M. Herold,et al.  Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. , 1993, Journal of the American College of Cardiology.

[19]  M. Sabatine,et al.  Prognostic Utility of Heart-Type Fatty Acid Binding Protein in Patients With Acute Coronary Syndromes , 2006, Circulation.

[20]  J. Marshall,et al.  Myocardial Injury and Ventricular Dysfunction Related to Training Levels Among Nonelite Participants in the Boston Marathon , 2006, Circulation.

[21]  J. Brugada,et al.  Long-lasting sport practice and lone atrial fibrillation. , 2002, European heart journal.

[22]  D. Warburton,et al.  Health benefits of physical activity: the evidence , 2006, Canadian Medical Association Journal.

[23]  Sarah Moretti,et al.  Effects of Mountain Ultra-Marathon Running on ROS Production and Oxidative Damage by Micro-Invasive Analytic Techniques , 2015, PloS one.

[24]  J. Brugada,et al.  Cardiac Arrhythmogenic Remodeling in a Rat Model of Long-Term Intensive Exercise Training , 2011, Circulation.

[25]  G. Hasenfuss,et al.  Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism. , 2010, Journal of the American College of Cardiology.

[26]  Hein Heidbuchel,et al.  Ventricular arrhythmias associated with long-term endurance sports: what is the evidence? , 2012, British Journal of Sports Medicine.

[27]  S. Agewall,et al.  Troponin and exercise. , 2016, International journal of cardiology.

[28]  S. Willich,et al.  Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[29]  C. Garlanda,et al.  Evolution of the Pentraxin Family: The New Entry PTX4 , 2010, The Journal of Immunology.

[30]  Richard T. Lee,et al.  IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. , 2007, The Journal of clinical investigation.

[31]  Yigal M. Pinto,et al.  Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction , 2004, Circulation.

[32]  C. Garlanda,et al.  The long pentraxin PTX3 in vascular pathology. , 2006, Vascular pharmacology.

[33]  A. Hall,et al.  Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. , 2007, Journal of the American College of Cardiology.

[34]  R. Shephard Pentraxin3 and high-sensitive C-reactive protein are independent inflammatory markers released during high-intensity exercise , 2011 .

[35]  S. Rubin,et al.  Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study , 2003, Circulation.

[36]  T. Mocan,et al.  Serum levels of the soluble IL-1 receptor family member ST2 and right ventricular dysfunction. , 2014, Biomarkers in medicine.

[37]  H. Heidbuchel,et al.  Relationship between Inflammatory Cytokines and Indices of Cardiac Dysfunction following Intense Endurance Exercise , 2015, PloS one.

[38]  M. Olschewski,et al.  Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension , 2008, European Respiratory Journal.